PRCT

PROCEPT BioRobotics Corporation is a healthcare company in the medical devices industry with a market capitalization of $1.85 billion and approximately 756 employees. The company's revenue has reached $299.91 million over the trailing twelve months. The company's financial health is characterized by negative profitability, with operating margin and profit margin both in the red at -27.8% and -28.2%, respectively. However, its gross margin stands at a relatively healthy 64.5%. The company's balance sheet shows cash of $294.28 million and debt of $78.93 million, resulting in a debt to equity ratio of 20.75. Additionally, the current ratio is a robust 8.44. The company's valuation context is marked by a negative forward price-to-earnings (P/E) ratio of -30.30 and an enterprise value to EBITDA (EV/EBITDA) of -17.40. Revenue growth has been strong at 42.8% year-over-year, but the lack of earnings growth data makes it difficult to assess the company's long-term profitability prospects. The dividend yield is not applicable due to a payout ratio of 0.0%.